Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The development of interval breast malignancies in patients with BRCA mutations.

Komenaka IK, Ditkoff BA, Joseph KA, Russo D, Gorroochurn P, Ward M, Horowitz E, El-Tamer MB, Schnabel FR.

Cancer. 2004 May 15;100(10):2079-83.

2.

Screening for hereditary breast cancer.

Dent R, Warner E.

Semin Oncol. 2007 Oct;34(5):392-400. Review.

PMID:
17920893
3.

Screening and follow-up of the patient at high risk for breast cancer.

Willey SC, Cocilovo C.

Obstet Gynecol. 2007 Dec;110(6):1404-16. Review.

PMID:
18055740
4.

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.

Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S.

Breast Cancer Res Treat. 2017 Apr;162(2):225-230. doi: 10.1007/s10549-017-4122-y. Epub 2017 Jan 30. Review.

PMID:
28138892
5.

Breast cancers detected with imaging screening in the BRCA population: emphasis on MR imaging with histopathologic correlation.

Causer PA, Jong RA, Warner E, Hill K, Wong JW, Curpen BN, Plewes DB.

Radiographics. 2007 Oct;27 Suppl 1:S165-82. doi: 10.1148/rg.27si075503. Review.

PMID:
18180225
6.

BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.

Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM, Balachandran A, Bhosale PR, McCullough AE, Menias CO.

Radiographics. 2017 Jul-Aug;37(4):1005-1023. doi: 10.1148/rg.2017160144. Epub 2017 May 26. Review.

PMID:
28548905
7.

BRCA Mutations and Breast Cancer Prevention.

Kotsopoulos J.

Cancers (Basel). 2018 Dec 19;10(12). pii: E524. doi: 10.3390/cancers10120524. Review.

Supplemental Content

Support Center